ArticleLancet regional health. Americas2026

Affordability of new drugs in the Brazilian public health system: a 13-year monitoring analysis of reimbursement decisions based on health technology assessments (2012-2024).

Daniel da Silva Pereira Curado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.